Roundtable discussion: Part II--Development of a pharmacoeconomic model in hypertension
Penna, P.; Cox, E.; Joseph, T.; Lehman, L.; Morrow, T.; Richter, A.; Sowers, J.; Tepper, D.
Managed care interface Suppl C: 17-23
2000
ISSN/ISBN: 1096-5645 PMID: 11183935 Document Number: 524272
Antihypertensive medications are targeted by most health plans as a major cost center. However, the efficacy of these medications, their side effects, and their resulting ability to prevent serious long-term complications must be factored into the value equation. To illustrate the possible economic effects of a single antihypertensive agent's inclusion on a health plan's drug formulary, an innovative pharmacoeconomic model was developed. In this portion of the roundtable, the design, results, and caveats of this model are discussed.